CopyMark Law Group
4.9/5
Drawing for RDI-STAT

USPTO serial 90355341

RDI-STAT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PAINTER, VALERIYA SHERMAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RDI-STAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Grace Han Stanton

Grace Han Stanton PERKINS COIE LLP1201 THIRD AVENUE, SUITE 4900SEATTLE, WA 98101United States

Goods and services

ClassDescriptionStatusFirst use
005Biopharmaceutical preparations for treating cancer, autoimmune diseases and infectious diseases; immunotherapeutic preparations for treating cancer, autoimmune diseases and infectious diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 22, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 22, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 5, 2024DOCKASSIGNED TO EXAMINER—
Dec 13, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 12, 2023EX5GSOU EXTENSION 5 GRANTED—
Dec 11, 2023EXT5SOU EXTENSION 5 FILED—
Dec 11, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 2, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 31, 2023EX4GSOU EXTENSION 4 GRANTED—
May 31, 2023EXT4SOU EXTENSION 4 FILED—
May 31, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 13, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 9, 2022EX3GSOU EXTENSION 3 GRANTED—
Dec 9, 2022EXT3SOU EXTENSION 3 FILED—
Dec 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 17, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 15, 2022EX2GSOU EXTENSION 2 GRANTED—
Jun 15, 2022EXT2SOU EXTENSION 2 FILED—
Jun 15, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 15, 2022EX1GSOU EXTENSION 1 GRANTED—
May 20, 2022NREVNOTICE OF REVIVAL - E-MAILED—
May 19, 2022TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
May 19, 2022PETGPETITION TO REVIVE-GRANTED—
May 19, 2022PROATEAS PETITION TO REVIVE RECEIVED—
May 18, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 18, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 28, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 21, 2021HSCDHIDDEN SENSITIVE CONTENT—
Dec 15, 2021EXT1SOU EXTENSION 1 FILED—
Dec 15, 2021EMRVEMAIL RECEIVED—
Jun 15, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 20, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 20, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 31, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 13, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 11, 2021DOCKASSIGNED TO EXAMINER—
Feb 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance